Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: If someone does have cancer, is an aggressive treatment like chemotherapy necessary? That’s the problem Ataraxis AI is trying to solve. The New York-based startup is focused on using AI to accurately predict not only if a patient h...